Market Research Logo

Hereditary Angioedema - Epidemiology Forecast to 2027

DelveInsight's Hereditary Angioedema - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Hereditary Angioedema epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Hereditary Angioedema Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hereditary Angioedema in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hereditary Angioedema outlook. It also includes the explanation of changing trends of epidemiology outlining the Hereditary Angioedema scenario.

Hereditary Angioedema Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hereditary Angioedema thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hereditary Angioedema explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hereditary Angioedema Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hereditary Angioedema

Key assessments
• Patient Segmentation in Hereditary Angioedema
• Hereditary Angioedema Risk & Burden
• Factors driving growth in a specific Hereditary Angioedema patient population


1. Report Introduction
2. Hereditary Angioedema Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hereditary Angioedema in 2017
2.2. Patient Share Distribution of Hereditary Angioedema in 2027
3. Disease Background and Overview: Hereditary Angioedema
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hereditary Angioedema in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hereditary Angioedema in 7MM – By Countries
5. Epidemiology of Hereditary Angioedema by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.1.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.1.4. Sex- Specific Cases of the Hereditary Angioedema *
5.1.5. Diagnosed Cases of the Hereditary Angioedema
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.4.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.4.4. Sex- Specific Cases of the Hereditary Angioedema *
5.4.5. Diagnosed Cases of the Hereditary Angioedema
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.5.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.5.4. Sex- Specific Cases of the Hereditary Angioedema *
5.5.5. Diagnosed Cases of the Hereditary Angioedema
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.6.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.6.4. Sex- Specific Cases of the Hereditary Angioedema *
5.6.5. Diagnosed Cases of the Hereditary Angioedema
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.7.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.7.4. Sex- Specific Cases of the Hereditary Angioedema *
5.7.5. Diagnosed Cases of the Hereditary Angioedema
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.8.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.8.4. Sex- Specific Cases of the Hereditary Angioedema *
5.8.5. Diagnosed Cases of the Hereditary Angioedema
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.9.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.9.4. Sex- Specific Cases of the Hereditary Angioedema *
5.9.5. Diagnosed Cases of the Hereditary Angioedema
6. Unmet Needs of the Hereditary Angioedema
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
List Of Tables
Table 1: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM
Table 2: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hereditary Angioedema in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Hereditary Angioedema in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Hereditary Angioedema in United States (2016-2027)*
Table 6: Diagnosed Cases of the Hereditary Angioedema in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Hereditary Angioedema in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Hereditary Angioedema in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Hereditary Angioedema in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Hereditary Angioedema in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Hereditary Angioedema in France (2016-2027)
Table 12: Sub-Type Specific cases of the Hereditary Angioedema in France (2016-2027) *
Table 13: Sex- Specific Cases of the Hereditary Angioedema in France (2016-2027) *
Table 14: Diagnosed Cases of the Hereditary Angioedema in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Hereditary Angioedema in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Hereditary Angioedema in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Hereditary Angioedema in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Hereditary Angioedema in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Hereditary Angioedema in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Hereditary Angioedema in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Hereditary Angioedema in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Hereditary Angioedema in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Hereditary Angioedema in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Hereditary Angioedema in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Hereditary Angioedema in UK (2016-2027) *
Table 26: Diagnosed Cases of the Hereditary Angioedema in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Hereditary Angioedema in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Hereditary Angioedema in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Hereditary Angioedema in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Hereditary Angioedema in Japan (2016-2027)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report